Respiri Limited
- Jurisdiction
Australia - ISIN
AU000000RSH4 (RSH.AX )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Fundamental strength relative to industry (Mohanram G-Value)
-
1
/ 7
Profile
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. Read full profile
Stock price
Fundamentals
- Net revenue
€1.15M - Gross margin
-80.3% - EBIT
-€8.10M - EBIT margin
-701.6% - Net income
-€7.82M - Net margin
-677.4%
Statement period: - (published )
Dividends
No dividend payouts